A recent study revealed that activation of macrophages by the infusion of antibodies against CD40 may induce macrophage-mediated tumour regression in 30% of cases in both a mouse model for pancreatic cancer and in patients with pancreatic cancer [66, 67]. This evidence concerns the gene CD40 and familial pancreatic carcinoma.